Does Rallies show 13F holders for ICUI?

Yes. Rallies tracks hedge fund and 13F ownership data for ICUI, including fund names, share counts, latest tracked quarter, and position changes when available.

Is ICUI research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ICUI. It does not provide personalized investment advice.

ICUI (ICU Medical Inc) Stock Analysis - Hedge Fund Holdings

ICU Medical Inc (ICUI) is a publicly traded Healthcare sector company. As of May 21, 2026, ICUI trades at $129.31 with a market cap of $3.08B and a P/E ratio of 67.68. ICUI moved +4.60% today. Year to date, ICUI is -10.28%; over the trailing twelve months it is -4.16%. Its 52-week range spans $107.00 to $196.26. Analyst consensus is buy with an average price target of $163.50. Rallies surfaces ICUI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns ICUI stock?

Hedge funds tracked by Rallies that own ICUI include Centerbook Partners, Bridgewater Associates, Panagora Asset, and Pinebridge Investments. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for ICU Medical Inc.

ICUI Key Metrics

Key financial metrics for ICUI
Metric	Value
Price	$129.31
Market Cap	$3.08B
P/E Ratio	67.68
EPS	$1.87
Dividend Yield	0.00%
52-Week High	$196.26
52-Week Low	$107.00
Volume	0
Avg Volume	0
Revenue (TTM)	$2.16B
Net Income	$46.34M
Gross Margin	37.93%

Top Hedge Funds Holding ICUI

Centerbook Partners holds 9.45K shares of ICUI, changed +0.00% as of Dec 31, 2024.
Bridgewater Associates holds 2.42K shares of ICUI, changed -30.28% as of Dec 31, 2024.
Panagora Asset holds 1.73K shares of ICUI, changed +20.70% as of Mar 31, 2026.
Pinebridge Investments holds 217 shares of ICUI, changed +0.00% as of Jun 30, 2023.

Latest ICUI News

ICU Medical Q4 EBITDA Down 7%, Integration Delays Keep 2026 Target Below $500M — Feb 20, 2026
ICU Medical Q4 Revenue Falls 13.8% to $535.9M While EPS Tops by 13.5% — Feb 20, 2026
ICU Medical Q4 Expected to Fall 14.6% to $530.9M, EPS $1.69 — Feb 18, 2026

Recent ICUI Insider Trades

Sanzone Virginia Ruth sold 2.45K (~$303.62K) on May 14, 2026.
Greenberg David C. sold 2.42K (~$297.93K) on May 12, 2026.
Woolson Daniel sold 2.90K (~$441.36K) on Nov 25, 2025.

ICUI Analyst Consensus

3 analysts cover ICUI: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $163.50.

Common questions about ICUI

Who owns ICUI stock?: Hedge funds tracked by Rallies that own ICUI include Centerbook Partners, Bridgewater Associates, Panagora Asset, and Pinebridge Investments. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for ICU Medical Inc.
Does Rallies show 13F holders for ICUI?: Yes. Rallies tracks hedge fund and 13F ownership data for ICUI, including fund names, share counts, latest tracked quarter, and position changes when available.
Is ICUI research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ICUI. It does not provide personalized investment advice.